Publications by authors named "Vikram B Wali"

28Publications

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer.

Sci Rep 2019 10 17;9(1):14934. Epub 2019 Oct 17.

Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.

View Article and Find Full Text PDF
October 2019

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity.

Cell Rep 2018 11;25(6):1446-1457

Department of Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Cancer Center, New Haven, CT, USA. Electronic address:

View Article and Find Full Text PDF
November 2018

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.

Oncotarget 2017 Mar;8(13):21733-21740

Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.

View Article and Find Full Text PDF
March 2017

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.

PLoS Med 2016 Dec 13;13(12):e1002193. Epub 2016 Dec 13.

Department of Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America.

View Article and Find Full Text PDF
December 2016

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer.

Cancer Res 2017 01 21;77(2):566-578. Epub 2016 Nov 21.

Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut.

View Article and Find Full Text PDF
January 2017

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.

Cancer Res 2016 Feb 16;76(4):927-39. Epub 2015 Dec 16.

Institute for RNA Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
February 2016

Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer.

BMC Genomics 2014 Oct 8;15:876. Epub 2014 Oct 8.

Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut, USA.

View Article and Find Full Text PDF
October 2014

Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.

Mol Cancer Res 2014 Aug 14;12(8):1140-55. Epub 2014 May 14.

Department of Pathology, Yale School of Medicine, New Haven, Connecticut.

View Article and Find Full Text PDF
August 2014

Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue.

Mol Oncol 2014 May 17;8(3):717-27. Epub 2014 Feb 17.

Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

View Article and Find Full Text PDF
May 2014

Tocotrienol combination therapy results in synergistic anticancer response.

Front Biosci (Landmark Ed) 2011 Jun 1;16:3183-95. Epub 2011 Jun 1.

College of Pharmacy, 700 University Avenue, University of Louisiana at Monroe, Monroe, LA 71209-0470, USA.

View Article and Find Full Text PDF
June 2011

Synthesis of fluorescent analogues of the anticancer natural products 4-hydroxyphenylmethylene hydantoin and delta-tocotrienol.

Nat Prod Commun 2010 Oct;5(10):1623-6

Department of Basic Pharmaceutical Sciences, College of Pharmacy, 1800 Bienville Drive, University of Louisiana at Monroe, Monroe, Louisiana 71201, USA.

View Article and Find Full Text PDF
October 2010

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors.

Bioorg Med Chem 2010 Nov 19;18(22):8066-75. Epub 2010 Sep 19.

Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, United States.

View Article and Find Full Text PDF
November 2010

Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.

Anticancer Res 2010 Feb;30(2):429-37

College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA.

View Article and Find Full Text PDF
February 2010